Schonfeld Strategic Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-379,001
| Closed | -$1.74M | – | 2416 |
|
|
2025
Q1 | $1.74M | Buy |
379,001
+108,460
| +40% | +$498K | 0.01% | 915 |
|
|
2024
Q4 | $1.3M | Buy |
+270,541
| New | +$1.3M | 0.01% | 955 |
|
|
2023
Q4 | – | Sell |
-22,241
| Closed | -$96.1K | – | 2091 |
|
|
2023
Q3 | $96.1K | Buy |
+22,241
| New | +$96.1K | ﹤0.01% | 1359 |
|
|
2022
Q4 | – | Sell |
-49,991
| Closed | -$494K | – | 2928 |
|
|
2022
Q3 | $494K | Buy |
+49,991
| New | +$494K | ﹤0.01% | 1732 |
|
|
2021
Q4 | – | Sell |
-10,000
| Closed | -$172K | – | 2380 |
|
|
2021
Q3 | $172K | Buy |
+10,000
| New | +$172K | ﹤0.01% | 1730 |
|
|
2020
Q1 | – | Sell |
-14,284
| Closed | -$235K | – | 1537 |
|
|
2019
Q4 | $235K | Buy |
+14,284
| New | +$235K | 0.01% | 1095 |
|
|
2016
Q4 | – | Sell |
-43,169
| Closed | -$719K | – | 658 |
|
|
2016
Q3 | $719K | Buy |
+43,169
| New | +$719K | 0.12% | 227 |
|